Can at Scale Drug Provision Improve the Health of the Targeted in Sub-Saharan Africa?
Adrienne Lucas and
Nicholas Wilson
No 23403, NBER Working Papers from National Bureau of Economic Research, Inc
Abstract:
The single largest item in the United States foreign aid health budget is antiretroviral therapy (ART) for the treatment of HIV/AIDS. Many supply- and demand-side factors in sub-Saharan Africa could cause smaller than expected epidemiological effects of this at scale drug provision. We provide what appears to be the first quasi-experimental evidence on the effect of at scale drug provision in a poor country, using the phased roll-out of ART in Zambia, a setting where approximately 1 in 6 adults are HIV positive. Combining anthropometric data from national household surveys and a spatially-based triple difference specification, we find that local ART introduction increased the weight of high HIV likelihood adult women. This finding from a clinically difficult setting suggest that the generalized challenges of scalability of ART for adult health in sub-Saharan Africa are surmountable.
JEL-codes: H51 I12 I15 I18 O12 O15 (search for similar items in EconPapers)
Date: 2017-05
New Economics Papers: this item is included in nep-afr and nep-hea
Note: CH DEV EH
References: View references in EconPapers View complete reference list from CitEc
Citations: View citations in EconPapers (2)
Published as Adrienne M. Lucas & Nicholas L. Wilson, 2018. "Can At-Scale Drug Provision Improve the Health of the Targeted in Sub-Saharan Africa?," American Journal of Health Economics, vol 4(3), pages 358-382.
Downloads: (external link)
http://www.nber.org/papers/w23403.pdf (application/pdf)
Related works:
Journal Article: Can At-Scale Drug Provision Improve the Health of the Targeted in Sub-Saharan Africa? (2018) 
Journal Article: Can At-Scale Drug Provision Improve the Health of the Targeted in Sub-Saharan Africa? (2018) 
This item may be available elsewhere in EconPapers: Search for items with the same title.
Export reference: BibTeX
RIS (EndNote, ProCite, RefMan)
HTML/Text
Persistent link: https://EconPapers.repec.org/RePEc:nbr:nberwo:23403
Ordering information: This working paper can be ordered from
http://www.nber.org/papers/w23403
Access Statistics for this paper
More papers in NBER Working Papers from National Bureau of Economic Research, Inc National Bureau of Economic Research, 1050 Massachusetts Avenue Cambridge, MA 02138, U.S.A.. Contact information at EDIRC.
Bibliographic data for series maintained by ().